Piper Sandler Maintains Neutral on Solid Biosciences, Lowers Price Target to $2
Piper Sandler analyst Allison Bratzel maintains Solid Biosciences (NASDAQ:SLDB) with a Neutral and lowers the price target from $5 to $2.
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
SVB Leerink Maintains Outperform on Solid Biosciences, Raises Price Target to $15
SVB Leerink analyst Joseph Schwartz maintains Solid Biosciences (NASDAQ:SLDB) with a Outperform and raises the price target from $12 to $15.
62 Biggest Movers From Yesterday
Gainers
Tenon Medical, Inc. (NASDAQ: TNON) rose 350% to clsoe at $22.50 on Wednesday after the company priced its IPO at $5.00 per share.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis
Here's a roundup of top developments in the biotech space over the last 24 hours.
Earnings Scheduled For April 27, 2022
Companies Reporting Before The Bell
• Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter.
50 Stocks Moving In Monday’s Mid-Day Session
Gainers
Volt Information Sciences, Inc. (NYSE: VOLT) shares jumped 95.2% to $5.89 after the company announced it would be acquired for $6 per share.